Literature DB >> 15167727

Gold weight implantation: a better way?

Robert N Tower1, Roger A Dailey.   

Abstract

PURPOSE: To introduce an alternative surgical technique for gold weight implantation for the treatment of lagophthalmos. We suggest that unwrapped intraorbital gold weight implantation provides adequate function, better cosmetic appearance, and lower morbidity than conventional implantation with wrapped or unwrapped pretarsal gold weights.
METHODS: The charts of a single surgeon were reviewed (1994 to 2003). All patients who underwent intraorbital gold weight implantation were included in the study. The technique was noted to be consistent with intraorbital fixation of a custom 2.2-gm gold weight (MedDev Corporation, Sunnyvale, California). Implants were not wrapped. Efficacy was defined as elimination of exposure keratopathy with preservation of the visual axis. Morbidity was defined as extrusion of the weight, shift of positioning requiring intervention, inflammation/infection of the eyelid, or poor cosmetic appearance.
RESULTS: Of 59 patient charts reviewed, 2 patients had morbidity as defined by our study: One had shifting of the gold weight, necessitating repositioning of the weight; the other had extrusion of the gold weight, requiring its removal. The remaining patients had no complaints or cosmetic concerns. Follow-up examinations found no incidence of exposure keratopathy.
CONCLUSIONS: We found intraorbital gold weight implantation, without the use of a wrap, to be simple and effective, with adequate function, an acceptably low postoperative morbidity rate, and an excellent cosmetic outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167727     DOI: 10.1097/01.iop.0000123500.19475.b0

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  1 in total

1.  Periocular and anterior orbital necrosis after upper eyelid gold weight loading: operation-related or self-inflicted?

Authors:  Roy Schwartz; Ran Ben Cnaan; Ophir Schein; Michael Giladi; Michal Raz; Igal Leibovitch
Journal:  Clin Ophthalmol       Date:  2014-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.